DOW: Held by 1 Biotech Hedge Fund (2026) | BiotechEdge

Catalysts Convergence Squeeze SignalsNEW Cash Runway Insiders M&A Research

Home›Companies›DOW INC. (DOW)

DOW INC.

DOW

Held by 1 specialist biotech fund

1 fund opened new positions. Next phase2 readout (Platelet rich fibrin): Apr 2025. Short interest: 4.0% of float.

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

1.5/10

1 fund opened new positions

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Feedback

●●

No recent insider activity●●

No upcoming catalysts●●

Held by 1 specialist fund●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

Deerfield Management

Position Trend

May 15, 2025

0 funds

Aug 14, 2025

0 funds

Nov 14, 2025

0 funds

Feb 17, 2026

0 funds

-100% total institutional value over 6 quarters

Short Interest

Short Shares

25.18M

Change

+11.0%

Days to Cover

1.6

% of Float

4.0%

Settlement

Apr 30, 2026

Short interest over 3 periods

Catalysts

Phase 2Q2 2025Platelet rich fibrinRate of Tooth Movement in Orthodontic PatientsNCT06634017

Phase 3Q3 2025Surgical Site Infection, Surgical Wound, Surgical IncisionNCT05989386

Phase 3Q4 2025Suture Techniques, Wound Closure Techniques, Laparotomy/StanderdsNCT07154277

Phase 2Q2 2026Pulpal NecrosisNCT07264842

Be first to know when this name moves

Fund buys and exits, insider activity, and catalyst alerts across 800+ biotechs — free Monday brief.

Position Details

Deerfield ManagementEXITFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

5 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

EHAB1 fund NVST1 fund MMSI1 fund ALNY1 fund DAWN1 fund DXCM1 fund BBNX1 fund IDYA1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer